UB Paderborn / Katalog / Suche / in CDI

Proposed research criteria for prodromal behavioural variant frontotemporal dementia

Brain (London, England : 1878), 2022-04, Vol.145 (3), p.1079-1097

2022

Volltextzugriff (PDF)

Development of Phenyl Cyclohexylcarboxamides as a Novel Class of Hsp90 C‐terminal Inhibitors

Chemistry : a European journal, 2017-11, Vol.23 (65), p.16574-16585

2017

Volltextzugriff (PDF)

Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials

Alzheimer's research & therapy, 2020-10, Vol.12 (1), p.137-137, Article 137

2020

Volltextzugriff (PDF)

Modified biphenyl Hsp90 C-terminal inhibitors for the treatment of cancer

Bioorganic & medicinal chemistry letters, 2017-09, Vol.27 (18), p.4514-4519

2017

Volltextzugriff (PDF)

The temporal onset of the core features in dementia with Lewy bodies

Alzheimer's & dementia, 2022-04, Vol.18 (4), p.591-601

2022

Volltextzugriff (PDF)

Feasibility of Intentional Technology Pairing in Fostering Connections Among Dementia Caregivers

Alzheimer's & dementia, 2022-12, Vol.18 (S2), p.e067871-n/a

2022

Volltextzugriff (PDF)

Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration

Journal of neurology, neurosurgery and psychiatry, 2023-07, Vol.94 (7), p.541

2023

Volltextzugriff (PDF)

Assessing network degeneration and phenotypic heterogeneity in genetic frontotemporal lobar degeneration by decoding FDG-PET

NeuroImage clinical, 2024, Vol.41, p.103559-103559, Article 103559

2024

Volltextzugriff (PDF)

Exploiting polarity and chirality to probe the Hsp90 C-terminus

Bioorganic & medicinal chemistry, 2018-07, Vol.26 (12), p.3096-3110

2018

Volltextzugriff (PDF)

Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies

Alzheimer's & dementia, 2024-04, Vol.20 (4), p.2485-2496

2024

Volltextzugriff (PDF)

The contribution of behavioral features to caregiver burden in FTLD spectrum disorders

Alzheimer's & dementia, 2022-09, Vol.18 (9), p.1635-1649

2022

Volltextzugriff (PDF)

Development of noviomimetics that modulate molecular chaperones and manifest neuroprotective effects

European journal of medicinal chemistry, 2018-01, Vol.143, p.1428-1435

2018

Volltextzugriff (PDF)

Technology‐assisted caregiver matching to address isolation and stress

Alzheimer's & dementia, 2021-12, Vol.17 (S7), p.e055692-n/a

2021

Volltextzugriff (PDF)

Assessing the needs of Black/African American dementia caregivers seeking emotional support

Alzheimer's & dementia, 2021-12, Vol.17 (S8), p.e056579-n/a

2021

Volltextzugriff (PDF)

Alternative approaches to Hsp90 modulation for the treatment of cancer

Future medicinal chemistry, 2014-09, Vol.6 (14), p.1587-1605

2014

Volltextzugriff (PDF)

Influences of amyloid-β and tau on white matter neurite alterations in dementia with Lewy bodies

NPJ Parkinson's Disease, 2024-04, Vol.10 (1), p.76-76, Article 76

2024

Volltextzugriff (PDF)

Development of Noviomimetics as C‑Terminal Hsp90 Inhibitors

ACS medicinal chemistry letters, 2016-01, Vol.7 (1), p.67-71

2016

Volltextzugriff (PDF)

Brain glucose metabolism and nigrostriatal degeneration in isolated rapid eye movement sleep behaviour disorder

Brain communications, 2023, Vol.5 (1), p.fcad021-fcad021

2023

Volltextzugriff (PDF)

Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants

JAMA network open, 2020-10, Vol.3 (10), p.e2022847-e2022847

2020

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Proposed research criteria for prodromal behavioural variant frontotemporal dementia

Development of Phenyl Cyclohexylcarboxamides as a Novel Class of Hsp90 C‐terminal Inhibitors

Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials

Modified biphenyl Hsp90 C-terminal inhibitors for the treatment of cancer

β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies

The temporal onset of the core features in dementia with Lewy bodies

Feasibility of Intentional Technology Pairing in Fostering Connections Among Dementia Caregivers

Neurite-based white matter alterations in MAPT mutation carriers: A multi-shell diffusion MRI study in the ALLFTD consortium

Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration

Assessing network degeneration and phenotypic heterogeneity in genetic frontotemporal lobar degeneration by decoding FDG-PET

Exploiting polarity and chirality to probe the Hsp90 C-terminus

Differences in Motor Features of C9orf72 , MAPT , or GRN Variant Carriers With Familial Frontotemporal Lobar Degeneration

Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies

Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal Dementia

The contribution of behavioral features to caregiver burden in FTLD spectrum disorders

Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia

Multisite ALLFTD study modeling progressive empathy loss from the earliest stages of behavioral variant frontotemporal dementia

Development of noviomimetics that modulate molecular chaperones and manifest neuroprotective effects

Technology‐assisted caregiver matching to address isolation and stress

Assessing the needs of Black/African American dementia caregivers seeking emotional support

Alternative approaches to Hsp90 modulation for the treatment of cancer

Influences of amyloid-β and tau on white matter neurite alterations in dementia with Lewy bodies

Development of Noviomimetics as C‑Terminal Hsp90 Inhibitors

Brain glucose metabolism and nigrostriatal degeneration in isolated rapid eye movement sleep behaviour disorder

Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants

Suchergebnisse filtern